SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-009993
Filing Date
2024-03-15
Accepted
2024-03-14 18:15:55
Documents
78
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2348255
2 ex23-1.htm EX-23.1 3760
3 ex31-1.htm EX-31.1 17650
4 ex31-2.htm EX-31.2 17646
5 ex32-1.htm EX-32.1 7565
6 ex32-2.htm EX-32.2 7532
7 ex97.htm EX-97.1 41273
8 form10-k_001.jpg GRAPHIC 77149
9 form10-k_002.jpg GRAPHIC 73920
  Complete submission text file 0001493152-24-009993.txt   9356881

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ensc-20231231.xsd EX-101.SCH 56300
11 XBRL CALCULATION FILE ensc-20231231_cal.xml EX-101.CAL 65544
12 XBRL DEFINITION FILE ensc-20231231_def.xml EX-101.DEF 282431
13 XBRL LABEL FILE ensc-20231231_lab.xml EX-101.LAB 472950
14 XBRL PRESENTATION FILE ensc-20231231_pre.xml EX-101.PRE 383127
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1188634
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38306 | Film No.: 24751677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)